Impact BioMedical Inc. (IBO)
NYSEAMERICAN: IBO · Real-Time Price · USD
0.639
-0.034 (-4.98%)
At close: Mar 9, 2026, 4:00 PM EDT
0.624
-0.015 (-2.33%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Impact BioMedical Revenue
Impact BioMedical had revenue of $18.00K in the quarter ending September 30, 2025. This brings the company's revenue in the last twelve months to $25.00K.
Revenue (ttm)
$25.00K
Revenue Growth
n/a
P/S Ratio
2,813.89
Revenue / Employee
$12,500
Employees
2
Market Cap
66.84M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pelthos Therapeutics | 7.41M |
| Coeptis Therapeutics Holdings | 501.00K |
| MediciNova | 409.66K |
| InflaRx | 73.73K |
| Fractyl Health | 3.00K |
IBO News
- 7 months ago - Impact Biomedical Inc (IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 9 months ago - Dr Ashleys Limited and Impact BioMedical Inc. Announce Strategic Merger - GlobeNewsWire
- 1 year ago - Impact Biomedical Inc. Announcement Stock Activity/Pricing - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. to Present at The Microcap Conference - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces Issuance of Canadian Patent for Linebacker™ Technology Targeting Inflammatory Disease - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE American: IBO) Announces IPO Participation with Strong Support from Partners and Affiliates - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. (NYSE: IBO) Announces 3F™ US Patent Issue - GlobeNewsWire
- 1 year ago - Impact BioMedical Inc. Announces the Closing of its Initial Public Offering - GlobeNewsWire